Title:Yokukansan, a Japanese Herbal Medicine, Suppresses Substance P-Induced Production of Interleukin-6 and Interleukin-8 by Human U373 MG Glioblastoma Astrocytoma Cells
Volume: 20
Issue: 7
Author(s): Keisuke Yamaguchi, Sho Yamazaki, Seiichiro Kumakura, Akimasa Someya, Masako Iseki, Eiichi Inada and Isao Nagaoka*
Affiliation:
- Department of Host Defense and Biochemical Research, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421,Japan
Keywords:
Yokukansan, substance P, p38MAPK, NF-κB, NK-1 receptor, anti-inflammatory action.
Abstract:
Background: Yokukansan is a traditional Japanese herbal medicine that has an antiallodynic
effect in patients with chronic pain. However, the mechanisms by which yokukansan inhibits
neuropathic pain are unclear.
Objective: This study aimed to investigate the molecular effects of yokukansan on neuroinflammation
in U373 MG glioblastoma astrocytoma cells, which express a functional high-affinity neurokinin 1
receptor (substance P receptor), and produce interleukin (IL)-6 and IL-8 in response to stimulation by
substance P (SP).
Methods: We assessed the effect of yokukansan on the expression of ERK1/2, P38 MAPK, nuclear
factor (NF)-κB, and cyclooxygenase-2 (COX-2) in U373 cells by western blot assay. Levels of IL-6
and IL-8 in conditioned medium obtained after stimulation of cells with SP for 24 h were measured by
enzyme-linked immunosorbent assay. All experiments were conducted in triplicate. Results were analyzed
by one-way ANOVA, and significance was accepted at p < 0.05.
Results: Yokukansan suppressed SP-induced production of IL-6 and IL-8 by U373 MG cells, and
downregulated SP-induced COX-2 expression. Yokukansan also inhibited phosphorylation of ERK1/2
and p38 MAPK, as well as nuclear translocation of NF-κB, induced by SP stimulation of U373 MG
cells.
Conclusion: Yokukansan exhibits anti-inflammatory activity by suppressing SP-induced production of
IL-6 and IL-8 and downregulating COX-2 expression in U373 MG cells, possibly via inhibition of the
activation of signaling molecules, such as ERK1/2, p38 MAPK, and NF-κB.